{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:13:23Z","timestamp":1772648003141,"version":"3.50.1"},"reference-count":132,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cancer metabolism is characterized by an increased utilization of fermentable fuels, such as glucose and glutamine, which support cancer cell survival by increasing resistance to both oxidative stress and the inherent immune system in humans. Dialysis has the power to shift the patient from a state dependent on glucose and glutamine to a ketogenic condition (KC) combined with low glutamine levels\u2014thereby forcing ATP production through the Krebs cycle. By the force of dialysis, the cancer cells will be deprived of their preferred fermentable fuels, disrupting major metabolic pathways important for the ability of the cancer cells to survive. Dialysis has the potential to reduce glucose levels below physiological levels, concurrently increase blood ketone body levels and reduce glutamine levels, which may further reinforce the impact of the KC. Importantly, ketones also induce epigenetic changes imposed by histone deacetylates (HDAC) activity (Class I and Class IIa) known to play an important role in cancer metabolism. Thus, dialysis could be an impactful and safe adjuvant treatment, sensitizing cancer cells to traditional cancer treatments (TCTs), potentially making these significantly more efficient.<\/jats:p>","DOI":"10.3390\/cancers14205054","type":"journal-article","created":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T21:10:10Z","timestamp":1665954610000},"page":"5054","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dialysis as a Novel Adjuvant Treatment for Malignant Cancers"],"prefix":"10.3390","volume":"14","author":[{"given":"Sture","family":"Hobro","sequence":"first","affiliation":[{"name":"Baxter International Inc., 226 43 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Baxter International Inc., 226 43 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sternby","sequence":"additional","affiliation":[{"name":"Baxter International Inc., 226 43 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"\u00d6berg","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Clinical Sciences, Skane University Hospital, Lund University, 221 85 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6738-4705","authenticated-orcid":false,"given":"Kristian","family":"Pietras","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University Cancer Centre, Medicon Village, 223 81 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Axelson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University Cancer Centre, Medicon Village, 223 81 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Carneiro","sequence":"additional","affiliation":[{"name":"Skane University Comprehensive Cancer Center, Skane University Hospital, Lund University, 222 41 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Kinhult","sequence":"additional","affiliation":[{"name":"Department of Oncology, Skane University Hospital, 221 85 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7328-8418","authenticated-orcid":false,"given":"Anders","family":"Christensson","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Skane University Hospital, Lund University, 205 02 Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Fors","sequence":"additional","affiliation":[{"name":"Baxter International Inc., 226 43 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"Baxter International Inc., Deerfield, MA 60015, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Knox","sequence":"additional","affiliation":[{"name":"Baxter International Inc., Old Toongabbie 2146, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innas","family":"Forsal","sequence":"additional","affiliation":[{"name":"Baxter International Inc., 226 43 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"K\u00e4llquist","sequence":"additional","affiliation":[{"name":"Baxter International Inc., 226 43 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Roos","sequence":"additional","affiliation":[{"name":"Baxter International Inc., 226 43 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"104500","DOI":"10.1016\/j.phrs.2019.104500","article-title":"Multi-dimensional roles of ketone bodies in cancer biology: Opportunities for cancer therapy","volume":"150","author":"Feng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1759091418818261","DOI":"10.1177\/1759091418818261","article-title":"Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis","volume":"10","author":"Chinopoulos","year":"2018","journal-title":"ASN Neuro"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnut.2020.00021","article-title":"Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer","volume":"7","author":"Seyfried","year":"2020","journal-title":"Front. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Seyfried, T.N., and Chinopoulos, C. (2021). Can the Mitochondrial Metabolic Theory Explain Better the Origin and Management of Cancer than Can the Somatic Mutation Theory?. Metabolites, 11.","DOI":"10.3390\/metabo11090572"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrc.2016.82","article-title":"Metabolic control of epigenetics in cancer","volume":"16","author":"Kinnaird","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphs.2019.10.007","article-title":"beta-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC\/survivin axis in human hepatocellular carcinoma cells","volume":"142","author":"Mikami","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12094-016-1497-x","article-title":"Survival in glioblastoma: A review on the impact of treatment modalities","volume":"18","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Jarosz-Biej, M., Smolarczyk, R., Cichon, T., and Kulach, N. (2019). Tumor Microenvironment as A \u201cGame Changer\u201d in Cancer Radiotherapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133212"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhou, W., and Wahl, D.R. (2019). Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance. Cancers, 11.","DOI":"10.3390\/cancers11091231"},{"key":"ref_15","first-page":"47","article-title":"Metabolism in tumor microenvironment: Implications for cancer immunotherapy","volume":"1","author":"Shi","year":"2020","journal-title":"Med. Comm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.molcel.2020.05.031","article-title":"Rational Cancer Treatment Combinations: An Urgent Clinical Need","volume":"78","author":"Boshuizen","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The Different Mechanisms of Cancer Drug Resistance: A Brief Review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wang, H., Jiang, H., Van de Gucht, M., and De Ridder, M. (2019). Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?. Cancers, 11.","DOI":"10.3390\/cancers11010112"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1667\/RR14668.1","article-title":"Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials","volume":"187","author":"Zahra","year":"2017","journal-title":"Radiat. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1172\/JCI106016","article-title":"Liver and kidney metabolism during prolonged starvation","volume":"48","author":"Owen","year":"1969","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ki.1994.339","article-title":"Amino acid and albumin losses during hemodialysis","volume":"46","author":"Ikizler","year":"1994","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneph.2015.38","article-title":"Haemodialysis-induced hypoglycaemia and glycaemic disarrays","volume":"11","author":"Abe","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nut.2013.07.024","article-title":"Tumor cell culture survival following glucose and glutamine deprivation at typical physiological concentrations","volume":"30","author":"Mathews","year":"2014","journal-title":"Nutrition"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semcancer.2020.09.010","article-title":"The effect of caloric restriction and fasting on cancer","volume":"73","author":"Alidadi","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson\u2019s disease: A pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MCO.0000000000000540","article-title":"The emerging role of ketogenic diets in cancer treatment","volume":"22","author":"Klement","year":"2019","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/ijc.28809","article-title":"Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer","volume":"135","author":"Poff","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/00004647-200010000-00012","article-title":"Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis","volume":"20","author":"Pan","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fphys.2017.00848","article-title":"On the Metabolism of Exogenous Ketones in Humans","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tibs.2019.01.005","article-title":"Ketoacidosis\u2014Where Do the Protons Come From?","volume":"44","author":"Green","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fonc.2018.00126","article-title":"Signaling Pathways Regulating Redox Balance in Cancer Metabolism","volume":"8","author":"Porporato","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101395","DOI":"10.1016\/j.redox.2019.101395","article-title":"Ketone bodies, stress response, and redox homeostasis","volume":"29","author":"Tapia","year":"2020","journal-title":"Redox Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.redox.2014.08.002","article-title":"Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism","volume":"2","author":"Allen","year":"2014","journal-title":"Redox Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.clnu.2015.01.013","article-title":"Toward a cancer-specific diet","volume":"35","author":"Bozzetti","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","article-title":"Ketogenic diet in the treatment of cancer\u2014Where do we stand?","volume":"33","author":"Weber","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: From the passenger to the driver\u2019s seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Cassim, S., and Pouyssegur, J. (2019). Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010157"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Grabacka, M., Pierzchalska, M., Dean, M., and Reiss, K. (2016). Regulation of Ketone Body Metabolism and the Role of PPARalpha. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122093"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC Inhibitors in Cancer Development and Therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119504","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1542-4758.2008.00256.x","article-title":"Glucose in the dialysate: Historical perspective and possible implications?","volume":"12","author":"Sharma","year":"2008","journal-title":"Hemodial. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.ajkd.2006.01.007","article-title":"The effect of glucose added to the dialysis fluid on blood pressure, blood glucose, and quality of life in hemodialysis patients: A placebo-controlled crossover study","volume":"47","author":"Sangill","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Li, M., Li, Y., Lv, J., Xu, H., Wu, X., Wen, W., Wang, W., and Yang, H. (2021). The effects of glucose-free and glucose-containing dialysate during dialysis in MHD patients: A prospective cross-over study. Perfusion, 2676591211042726.","DOI":"10.1177\/02676591211042726"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/ndt\/gfl710","article-title":"Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis","volume":"22","author":"Burmeister","year":"2007","journal-title":"Nephrol Dial. Transpl."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: A systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"ref_47","first-page":"357","article-title":"Adverse effects of hemodialysis on kidney patients: How good the evidence is","volume":"4","author":"Goudarzian","year":"2015","journal-title":"Int. J. Med. Investig."},{"key":"ref_48","unstructured":"Daugirdas, J.T., Blake, P.G., and Ing, T.D. (2014). Handbook Of Dialysis, Wolters Kluwer Health. [5th ed.]."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/00365517309084355","article-title":"Liver glycogen in man\u2014The effect of total starvation or a carbohydrate-poor diet followed by carbohydrate refeeding","volume":"32","author":"Nilsson","year":"1973","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI119644","article-title":"Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study","volume":"100","author":"Hellerstein","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mehy.2010.09.006","article-title":"High-glycolytic cancers and their interplay with the body\u2019s glucose demand and supply cycle","volume":"76","author":"Mathews","year":"2011","journal-title":"Med. Hypotheses"},{"key":"ref_52","first-page":"M573","article-title":"A regional blood circulation alternative to in-series two compartment urea kinetic modeling","volume":"39","author":"Schneditz","year":"1993","journal-title":"ASAIO J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1470-2045(00)00257-6","article-title":"Clinical role of positron emission tomography in oncology","volume":"2","author":"Bomanji","year":"2001","journal-title":"Lancet Oncol."},{"key":"ref_54","unstructured":"Todd, A.J. (2008). Inclusion of a Glycogen Regulation Mathematical Model into a Contextual Metabolic Framework. [Ph.D. Thesis, University of North Carolina]."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1152\/ajpendo.90563.2008","article-title":"Four grams of glucose","volume":"296","author":"Wasserman","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/CAD.0000000000000243","article-title":"Administration of chemotherapy in patients on dialysis","volume":"26","author":"Kuo","year":"2015","journal-title":"Anticancer. Drugs"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/annonc\/mdp598","article-title":"Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients","volume":"21","author":"Janus","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"23836","DOI":"10.1038\/s41598-021-03450-1","article-title":"Conceptual model of adding antibiotics to dialysate fluid during renal replacement therapy","volume":"11","author":"Bartuseviciene","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.radonc.2013.02.013","article-title":"Radiation induces aerobic glycolysis through reactive oxygen species","volume":"106","author":"Zhong","year":"2013","journal-title":"Radiother Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s42003-019-0455-x","article-title":"Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma","volume":"2","author":"Mukherjee","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10585-021-10102-1","article-title":"Cancer cell metabolic plasticity in migration and metastasis","volume":"38","author":"Mosier","year":"2021","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: Glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.ircmb.2016.06.006","article-title":"Metabolic Regulation of Apoptosis in Cancer","volume":"327","author":"Matsuura","year":"2016","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"11806","DOI":"10.18632\/oncotarget.3688","article-title":"Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models","volume":"6","author":"Bianchi","year":"2015","journal-title":"Oncotarget"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.3390\/ijms160922830","article-title":"Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach","volume":"16","author":"Chen","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4062\/biomolther.2017.179","article-title":"The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy","volume":"26","author":"Cho","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/bjc.2017.118","article-title":"One-carbon metabolism in cancer","volume":"116","author":"Newman","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1038\/oncsis.2015.50","article-title":"Hypoxia and metabolic adaptation of cancer cells","volume":"5","author":"Eales","year":"2016","journal-title":"Oncogenesis"},{"key":"ref_69","first-page":"36","article-title":"Taming Tumor Glycolysis and Potential implications for immunotherapy","volume":"7","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","article-title":"Lactate: A Metabolic Key Player in Cancer","volume":"71","author":"Hirschhaeuser","year":"2011","journal-title":"Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2015.447","article-title":"Glutaminolysis as a target for cancer therapy","volume":"35","author":"Jin","year":"2016","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.7150\/jca.64195","article-title":"Glutamate dehydrogenase 1 mediated glutaminolysis sustains HCC cells survival under glucose deprivation","volume":"13","author":"Zhou","year":"2022","journal-title":"J. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: Cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1177271918755391","DOI":"10.1177\/1177271918755391","article-title":"Reactive Oxygen Species: A Key Constituent in Cancer Survival","volume":"13","author":"Kumari","year":"2018","journal-title":"Biomark Insights"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"107864","DOI":"10.1016\/j.pharmthera.2021.107864","article-title":"In cancer, all roads lead to NADPH","volume":"226","author":"Rather","year":"2021","journal-title":"Pharm. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1158\/1078-0432.CCR-12-0287","article-title":"Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts","volume":"19","author":"Allen","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fonc.2017.00117","article-title":"Escaping Death: Mitochondrial Redox Homeostasis in Cancer Cells","volume":"7","author":"Ciccarese","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative Stress in Cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_79","first-page":"321","article-title":"NADPH homeostasis in cancer: Functions, mechanisms and therapeutic implications","volume":"5","author":"Ju","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","article-title":"NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism","volume":"1","author":"Chen","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"102065","DOI":"10.1016\/j.redox.2021.102065","article-title":"Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions","volume":"46","author":"Ying","year":"2021","journal-title":"Redox Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-2-18","article-title":"Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia","volume":"2","author":"Shukla","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000517305","article-title":"Starvation Ketosis and the Kidney","volume":"52","author":"Palmer","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1210\/jcem-52-1-34","article-title":"Suppression of glucose production and stimulation of insulin secretion by physiological concentrations of ketone bodies in man","volume":"52","author":"Miles","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI111408","article-title":"Effect of ketone bodies on glucose production and utilization in the miniature pig","volume":"74","author":"Muller","year":"1984","journal-title":"J. Clin. Investig."},{"key":"ref_87","unstructured":"Martuscello, R.T. (2015). Metabolic Intervention for the Treatment of Glioblastoma. [Ph.D. Thesis, ProQuest Dissertations Publishing]."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1194\/jlr.M082040","article-title":"Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo","volume":"59","author":"Zhang","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Licha, D., Vidali, S., Aminzadeh-Gohari, S., Alka, O., Breitkreuz, L., Kohlbacher, O., Reischl, R.J., Feichtinger, R.G., Kofler, B., and Huber, C.G. (2019). Untargeted Metabolomics Reveals Molecular Effects of Ketogenic Diet on Healthy and Tumor Xenograft Mouse Models. Int. J. Mol. Sci., 20.","DOI":"10.20944\/preprints201906.0275.v1"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"101761","DOI":"10.1016\/j.isci.2020.101761","article-title":"On the Origin of ATP Synthesis in Cancer","volume":"23","author":"Seyfried","year":"2020","journal-title":"iScience"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2017.04.005","article-title":"Mitochondrial ROS control of cancer","volume":"47","author":"Idelchik","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2014.09.015","article-title":"Hypoxia and free radicals: Role in tumor progression and the use of engineering-based platforms to address these relationships","volume":"79","author":"Hielscher","year":"2015","journal-title":"Free Radic. Bio. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcell.2018.00090","article-title":"Beyond the Warburg Effect: How Do Cancer Cells Regulate One-Carbon Metabolism?","volume":"6","author":"Rosenzweig","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13110","article-title":"Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides","volume":"508","author":"Birsoy","year":"2014","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"beta-Hydroxybutyrate: A Signaling Metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu. Rev. Nutr."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2006.11.065","article-title":"Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation","volume":"145","author":"Maalouf","year":"2007","journal-title":"Neuroscience"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fnut.2018.00062","article-title":"Nutritional Ketosis Increases NAD(+)\/NADH Ratio in Healthy Human Brain: An in Vivo Study by (31)P-MRS","volume":"5","author":"Xin","year":"2018","journal-title":"Front. Nutr."},{"key":"ref_98","first-page":"119","article-title":"Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth","volume":"3","author":"Yang","year":"2022","journal-title":"Medcine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"100941","DOI":"10.1016\/j.preteyeres.2021.100941","article-title":"Uncoupling proteins in the mitochondrial defense against oxidative stress","volume":"83","author":"Hass","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/09553002.2017.1380330","article-title":"The influence of ketogenic therapy on the 5 R\u2019s of radiobiology","volume":"95","author":"Klement","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000484045","article-title":"Fasting, Fats, and Physics: Combining Ketogenic and Radiation Therapy against Cancer","volume":"25","author":"Klement","year":"2018","journal-title":"Complement Med. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cmet.2018.03.013","article-title":"Immune Evasion in Tumor\u2019s Own Sweet Way","volume":"27","author":"Tang","year":"2018","journal-title":"Cell Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: Effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Perez-Tomas, R., and Perez-Guillen, I. (2020). Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers, 12.","DOI":"10.3390\/cancers12113244"},{"key":"ref_106","first-page":"121829","article-title":"Unravelling the Interplay between Extracellular Acidosis and Immune Cells","volume":"2018","author":"Diaz","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.0902584","article-title":"Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes","volume":"184","author":"Dietl","year":"2010","journal-title":"J. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy","volume":"76","author":"Kodumudi","year":"2016","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e145207","DOI":"10.1172\/jci.insight.145207","article-title":"Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade","volume":"6","author":"Ferrere","year":"2021","journal-title":"JCI Insight"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Lussier, D.M., Woolf, E.C., Johnson, J.L., Brooks, K.S., Blattman, J.N., and Scheck, A.C. (2016). Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2337-7"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s13046-019-1409-3","article-title":"Targeting T cell metabolism in the tumor microenvironment: An anti-cancer therapeutic strategy","volume":"38","author":"Yin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Ari, C., Murdun, C., Koutnik, A.P., Goldhagen, C.R., Rogers, C., Park, C., Bharwani, S., Diamond, D.M., Kindy, M.S., and D\u2019Agostino, D.P. (2019). Exogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models. Nutrients, 11.","DOI":"10.3390\/nu11102330"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Poff, A.M., Ari, C., Seyfried, T.N., and D\u2019Agostino, D.P. (2013). The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065522"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41387-020-00142-z","article-title":"Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: A systematic review and meta-analysis","volume":"10","author":"Yuan","year":"2020","journal-title":"Nutr. Diabetes"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1016\/j.cclet.2021.06.032","article-title":"Sodium bicarbonate, an inorganic salt and a potential active agent for cancer therapy","volume":"32","author":"Wang","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1681\/ASN.2016070780","article-title":"Bicarbonate Balance and Prescription in ESRD","volume":"28","author":"Abramowitz","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1681\/ASN.2016121344","article-title":"How Dangerous Is Hyperkalemia?","volume":"28","author":"Montford","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_118","first-page":"39","article-title":"Tumor lysis syndrome in the emergency department: Challenges and solutions","volume":"7","year":"2015","journal-title":"Open Access Emerg. Med."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Karagiannis, D., and Rampias, T. (2021). HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity. Cancers, 13.","DOI":"10.3390\/cancers13143575"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fgene.2018.00427","article-title":"Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets","volume":"9","author":"Lameirinhas","year":"2018","journal-title":"Front. Genet."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"8797206","DOI":"10.1155\/2016\/8797206","article-title":"HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases","volume":"2016","author":"Hull","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biocel.2018.03.004","article-title":"HDAC inhibitors as epigenetic regulators for cancer immunotherapy","volume":"98","author":"Conte","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: The potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00262-017-2091-y","article-title":"The class I\/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy","volume":"67","author":"Briere","year":"2018","journal-title":"Cancer Immunol. Immun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","article-title":"Ketone bodies as signaling metabolites","volume":"25","author":"Newman","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Dabek, A., Wojtala, M., Pirola, L., and Balcerczyk, A. (2020). Modulation of Cellular Biochemistry, Epigenetics and Metabolomics by Ketone Bodies. Implications of the Ketogenic Diet in the Physiology of the Organism and Pathological States. Nutrients, 12.","DOI":"10.3390\/nu12030788"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/cb500846u","article-title":"Metabolic regulation of histone post-translational modifications","volume":"10","author":"Fan","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4068\/cmj.2016.52.1.1","article-title":"HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases","volume":"52","author":"Yoon","year":"2016","journal-title":"Chonnam. Med. J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"578011","DOI":"10.3389\/fgene.2020.578011","article-title":"Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials","volume":"11","author":"Silver","year":"2020","journal-title":"Front. Genet."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2016.00081","article-title":"Inhibition of HDAC3-and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-induced Autophagy and Viability Reduction in Breast Cancer Cells","volume":"7","author":"Lee","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1743-7075-7-74","article-title":"The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma","volume":"7","author":"Stafford","year":"2010","journal-title":"Nutr. Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-020-03431-w","article-title":"The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma","volume":"147","author":"Vallejo","year":"2020","journal-title":"J. Neurooncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/20\/5054\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:54:46Z","timestamp":1760144086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/20\/5054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":132,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["cancers14205054"],"URL":"https:\/\/doi.org\/10.3390\/cancers14205054","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]}}}